Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/NEXUS BIOPHARMA INC/ 8-K

Current Report · 8-K

NEXUS BIOPHARMA INC

Current Report

Filed Mar 16, 2017Accepted Mar 16, 2017, 12:55 PM EDTCIK 1424151Accession 0001078782-17-000321
View company →Permanent SEC source ↗
Share

Company context

Historical securities (1)
NEXSNASDAQ · EQUITY · Historical · closed Jun 25, 2021

Recent company filings

  1. REVOKED filingJun 28, 2021
  2. 10-Q filingOct 27, 2017
  3. NT 10-Q filingJul 17, 2017
  4. 10-K filingJul 5, 2017
  5. NT 10-K filingMay 30, 2017

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗